Rapid PE Triage and Notification (PETN) vs Study Watch
AI Verdict
Choose Rapid PE Triage and Notification (PETN) if…
Choose Rapid PE Triage and Notification (PETN) if your primary need is to rapidly identify and prioritize suspected central pulmonary embolisms from CTPA scans in acute care settings. This tool is ideal for emergency departments and critical care units aiming to accelerate diagnosis, streamline clinician workflow, and improve time-sensitive patient management for PE.
View Rapid PE Triage and Notification (PETN) →Choose Study Watch if…
Choose Verily Study Watch if your objective is to conduct continuous, long-term physiological monitoring for clinical research studies. This wearable device is best suited for collecting rich, multi-sensor data like ECG and heart rate over extended periods to support research into disease progression, treatment efficacy, or general health trends within a study cohort.
View Study Watch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid PE Triage and Notification (PETN) | Study Watch |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | On-premise Rapid Server (dedicated or virtual) within hospital LAN/firewall, or Rapid Edge Cloud Platform. | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid PE Triage and Notification (PETN)Rapid PE Triage and Notification (Tool A) excels in usability for clinicians by integrating directly into existing hospital workflows, providing real-time notifications via PACS, email, and mobile apps. This streamlines urgent decision-making and accelerates patient care pathways. While Verily Study Watch (Tool B) is designed for patient ease of use as a wearable, its primary function is data collection for research, with data viewable by healthcare professionals through a separate portal, making Tool A more directly 'usable' in an acute clinical setting.
Clinical Value
Rapid PE Triage and Notification (PETN)Rapid PE Triage and Notification (Tool A) offers immediate, life-saving clinical value by rapidly identifying suspected central pulmonary embolisms from CTPA images, with demonstrated 94% sensitivity and 93% specificity. This directly accelerates diagnosis and treatment for a critical condition. Verily Study Watch (Tool B), while FDA-cleared for ECG and irregular pulse monitoring and valuable for continuous data collection in research, contributes more to long-term understanding and management rather than acute, time-critical interventions.
Pricing & Value
TieBoth tools lack publicly disclosed pricing information, making a direct comparison of their cost impossible. While RapidAI (Tool A) has demonstrated quantifiable ROI for other products through efficiency gains and increased revenue, and some of its products are eligible for NTAP reimbursement, specific value propositions for PETN versus the Study Watch's research-focused utility cannot be definitively compared without more data.
Enterprise Readiness
Rapid PE Triage and Notification (PETN)Rapid PE Triage and Notification (Tool A) demonstrates stronger enterprise readiness with flexible deployment options (on-premise or cloud) and explicit design for integration into core hospital IT infrastructure like PACS and EMR. RapidAI also offers 24/7 support and is a well-established company. While Verily Study Watch (Tool B) is FDA-cleared and HIPAA compliant, its primary focus on clinical research and an ongoing lawsuit regarding BAA/HIPAA, even if denied, could pose additional considerations for broader enterprise adoption in direct patient care workflows.
Innovation
TieBoth tools represent significant innovation in their respective domains. Rapid PE Triage and Notification (Tool A) innovates by applying AI to accelerate critical diagnostic pathways in radiology for a time-sensitive condition. Verily Study Watch (Tool B) innovates in continuous, multi-modal physiological data collection via a prescription-only wearable for clinical research and remote monitoring, pushing the boundaries of precision health. Their distinct yet impactful contributions to healthcare technology make this a tie.
Support & Docs
Rapid PE Triage and Notification (PETN)RapidAI (Tool A) provides comprehensive support, including 24/7/365 customer support via email and phone with multilingual technical experts, along with extensive resources like a help center, guides, webinars, and a dedicated training program (RapidU). While Verily Study Watch (Tool B) offers user manuals, its publicly available support and documentation details are less extensive and do not specify 24/7 availability or a broad range of educational materials.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid PE Triage and Notification (PETN) | Study Watch |
|---|---|---|
| Name | Rapid PE Triage and Notification (PETN) | Study Watch |
| Company | RapidAI (formerly iSchemaView) | Verily Life Sciences |
| Description | AI-powered software that analyzes CTPA images to rapidly identify and notify clinicians of suspected central pulmonary embolisms, streamlining workflow and accelerating patient care pathways. | Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. |
| Tagline | Accelerate your PE care pathways | Powering AI-enabled precision health solutions that accelerate research and improve care for individuals and communities. |
| Key Features | AI/ML module for CTPA image analysis; Detection of suspected central pulmonary embolism (PE); Workflow triage and prioritization; Real-time notifications to clinicians (PACS, email, mobile app); Compressed preview images (not for diagnostic use); Operates in parallel with standard of care; Integration within the Rapid Platform; Mobile and desktop application access | Continuous physiological monitoring; Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements); Long battery life (up to one week); Internal data storage and encryption; Cloud-based data processing with algorithms and machine learning; On-demand single-channel ECG; Irregular pulse monitor; E-ink display for minimal power consumption |
| Categories | Cardiology AI, Radiology & Imaging AI, Triage & ER/ICU AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology, Neurology, Sleep Medicine |
Videos
Demos, reviews, and walkthroughs featuring Rapid PE Triage and Notification (PETN) and Study Watch.